To the improvement of immunotherapeutic effects, self-assembled peptides are also developed for delivery of programmed cell death receptor 1/ligand 1 (PD-1/PD-L1) antibodies and related mimetic peptides, cancer antigens or epitope peptides, chimeric antigen receptor T cells, and so on. The gene discussed is CD274; the disease is cancer.